In primary NSCLC carcinomas from 42 patients: Western blot analysis. MET increased 2 to 10 fold in 25%, HGF overexpressed 10-100 fold compared with adjacent normal tissue. In IHC, MET/HGF homogeneous expression in carcinomas. Here, MET is linked to non-small cell lung carcinoma.